MoneyWorks4Me

The December 2023 quarter revenue stood at Rs. 1616.99 millions, up 6.13% as compared to Rs. 1523.57 millions during the corresponding quarter last year.The Company's Net profit for the December 2023 quarter have declined marginally to Rs. 157.00  millions as against Rs. 222.83 millions reported during the corresponding quarter ended.Operating profit for the quarter ended December 2023 decreased to 263.99 millions as compared to 338.15 millions of corresponding quarter ended December 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 1616.99 1523.57 6.13 4676.46 4303.51 8.67 6167.34 5201.35 18.57
Other Income 28.70 30.19 -4.94 52.31 44.92 16.45 43.20 27.62 56.41
PBIDT 263.99 338.15 -21.93 727.44 863.36 -15.74 1269.82 1079.38 17.64
Interest 25.56 11.88 115.15 38.38 18.19 111.00 24.14 64.07 -62.32
PBDT 238.43 326.27 -26.92 371.52 845.17 -56.04 1245.68 1015.31 22.69
Depreciation 35.03 30.59 14.51 103.31 89.16 15.87 123.42 100.80 22.44
PBT 203.40 295.68 -31.21 268.21 756.01 -64.52 1122.26 914.51 22.72
TAX 46.40 72.85 -36.31 152.17 194.18 -21.63 288.82 195.04 48.08
Deferred Tax 6.25 8.25 -24.24 16.10 19.09 -15.66 25.05 27.83 -9.99
PAT 157.00 222.83 -29.54 116.04 561.83 -79.35 833.44 719.47 15.84
Equity 368.81 364.37 1.22 368.81 364.37 1.22 364.37 364.37 0.00
PBIDTM(%) 16.33 22.19 -26.44 15.56 20.06 -22.46 20.59 20.75 -0.78
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..